Neuroblastoma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2]Haytham Allaham, M.D. [3]

Surgical intervention is curative as a single therapeutic modality for management of low risk neuroblastoma patients. In intermediate risk patients, surgical intervention must be followed by chemotherapy. However, the benefits of surgery to achieve complete tumor resection in high risk patients with metastatic disease is not clearly demonstrated.

• Surgical intervention alone may be curative as a single therapeutic modality for the management of low risk neuroblastoma patients.^[1]
• Surgical intervention must be followed by chemotherapy for the management of intermediate risk neuroblastoma patients.^[2]
• The potential benefit of aggressive surgical approaches to achieve complete tumor resection in high-risk patients with metastatic disease has not been clearly demonstrated.^{[3][4][5][6][7]}
• Surgical complications following neuroblastoma resection may include:^[8]

• Intussusception
• Internal haemorrhage due to vessel injuries
• Nerve injuries

Template:WikiDoc Sources